Organon & Co. (OGN) Stock Price

13.89 +0.00 (+0.00%)
Open: 13.86 Vol: 51.47K Day's range: 13.86 - 13.89 Nov 11, 15:59 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
OGN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 13.88▲ 13.88▲ 13.87▲ 13.86▲ 13.82▲
MA10 13.88▲ 13.87▲ 13.87▲ 13.84▲ 13.77▲
MA20 13.88▲ 13.87▲ 13.86▲ 13.80▲ 13.70▲
MA50 13.87▲ 13.85▲ 13.85▲ 13.75▲ 11.14▲
MA100 13.87▲ 13.84▲ 13.81▲ 13.67▲ 11.22▲
MA200 13.86▲ 13.81▲ 13.79▲ 11.70▲ 15.35▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▲ 0.001▲ 0.002▲ 0.008▲ -0.158▼
RSI 71.876▲ 69.017▲ 65.764▲ 64.664▲ 71.762▲
STOCH 16.667▼ 53.333     68.750     78.297     85.599▲
WILL %R 0.000▲ 0.000▲ 0.000▲ 0.000▲ 0.000▲
CCI 350.000▲ 152.874▲ 117.419▲ 115.380▲ 168.504▲
Latest Filters Detected On OGN
▲ BREAK $OGN Price Breaks 60 Days High Set Alert
▲ BREAK $OGN Price Breaks 30 Days High Set Alert
▲ BREAK $OGN Price Breaks 20 Days High Set Alert
▲ BREAK $OGN Price Breaks 10 Days High Set Alert
CDL $OGN Engulfing Candlestick Pattern Detected Set Alert
CDL $OGN Marubozu Candlestick Pattern Detected Set Alert
Organon & Co. News
New Real-World Evidence Presented by Organon at the American College of Rheumatology (ACR) Annual Meeting Evaluated a Large-Scale Switch to HADLIMA® (adalimumab-bwwd) Across ...
Saturday, November 07, 2026 07:00 AM
Analysis of over 16,000 patients switched to HADLIMA® from HUMIRA® (adalimumab) showed a 1.3% switchback rate over a 12-month follow-up period1 Data demonstrated the switching cohort had an average ...
Are TBRG, OGN, MDV Obtaining Fair Deals for their Shareholders?
Thursday, June 25, 2026 10:58 AM
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers.
Organon (NYSE:OGN) misses Q1 CY2026 revenue estimates
Thursday, April 30, 2026 03:11 PM
Pharmaceutical company Organon (NYSE:OGN) in Q1 CY2026, with sales falling 3.5% year on year to $1.46 billion. Its non-GAAP profit of $0.71 per share was 16.8% below analysts’ consensus estimates. Is ...
OGN historical stock data
date open high low close volume
11/11/26 13.86 13.89 13.86 13.89 1,597,211
10/11/26 13.83 13.89 13.83 13.89 2,355,741
09/11/26 13.87 13.88 13.82 13.85 2,503,102
06/11/26 13.80 13.87 13.78 13.87 3,947,166
05/11/26 13.86 13.86 13.79 13.79 3,750,911
04/11/26 13.833 13.88 13.83 13.83 2,172,358
03/11/26 13.83 13.85 13.825 13.85 3,657,853
02/11/26 13.85 13.85 13.82 13.82 2,146,912
30/10/26 13.83 13.84 13.805 13.84 1,845,288
29/10/26 13.76 13.83 13.76 13.81 2,510,010
Quote Details
52wk Low:5.69
52wk High:13.89
Vol:51.47K
Avg Vol(3m):41.6M
1Y Chng:+80.16%
1M Chng:+1.31%
Add to Watch List
More Information
Index N/A
Market Cap. 3.64B